TIDMSKP

RNS Number : 5797A

Skyepharma PLC

08 June 2016

.

 
 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i) 
-------------------------------------------------- 
 
 
 
 1. Identity of the issuer or                                     Skyepharma PLC 
  the underlying issuer 
  of existing shares to which 
  voting rights are 
  attached: (ii) 
---------------------------------------------------------------  ----------------------------- 
 2 Reason for the notification (please tick the appropriate 
  box or boxes): 
---------------------------------------------------------------------------------------------- 
 An acquisition or disposal of voting rights 
------------------------------------------------------------------  -------------------------- 
 An acquisition or disposal of qualifying financial 
  instruments which may result in the acquisition 
  of shares already issued to which voting rights 
  are attached 
------------------------------------------------------------------  -------------------------- 
 An acquisition or disposal of instruments with                                  x 
  similar economic effect to qualifying financial 
  instruments 
------------------------------------------------------------------  -------------------------- 
 An event changing the breakdown of voting rights 
------------------------------------------------------------------  -------------------------- 
 Other (please 
  specify): 
---------------------------------------------------------  -------  -------------------------- 
 3. Full name of person(s)                                    Syquant Capital 
  subject to the 
  notification obligation: 
  (iii) 
-----------------------------------------------------------  --------------------------------- 
 4. Full name of shareholder(s) 
  (if different from 3.):(iv) 
-----------------------------------------------------------  --------------------------------- 
 5. Date of the transaction                                   03/06/2016 
  and date on 
  which the threshold is 
  crossed or 
  reached: (v) 
-----------------------------------------------------------  --------------------------------- 
 6. Date on which issuer                                      07/06/2016 
  notified: 
-----------------------------------------------------------  --------------------------------- 
 7. Threshold(s) that is/are                                  Holding has gone above 3% 
  crossed or 
  reached: (vi, vii) 
-----------------------------------------------------------  --------------------------------- 
 
 
 
 8. Notified details: 
------------------------------------------------------------------------------------------------------ 
 A: Voting rights attached to shares (viii, ix) 
------------------------------------------------------------------------------------------------------ 
 Class/type    Situation previous              Resulting situation after the 
 of             to the triggering               triggering transaction 
 shares         transaction 
 
 if possible 
 using 
 the ISIN 
 CODE 
------------  ------------------------------  -------------------------------------------------------- 
               Number          Number          Number         Number of             % of voting 
               of               of              of shares      voting                rights (x) 
               Shares           Voting                         rights 
                                Rights 
------------  --------------  --------------  -------------  --------------------  ------------------- 
                                               Direct         Direct   Indirect     Direct    Indirect 
                                                              (xi)      (xii) 
------------    ------------   ------------   -------------  -------  -----------  --------  --------- 
 
 
 
 B: Qualifying Financial Instruments 
------------------------------------------------------------------------------------------------------ 
 Resulting situation after the triggering transaction 
------------------------------------------------------------------------------------------------------ 
 Type of         Expiration     Exercise/                     Number of voting      % of voting 
 financial        date           Conversion                    rights that           rights 
 instrument       (xiii)         Period (xiv)                  may be 
                                                               acquired if 
                                                               the 
                                                               instrument 
                                                               is 
                                                               exercised/ 
                                                               converted. 
--------------  -------------  ----------------------------  --------------------  ------------------- 
 
 
 C: Financial Instruments with similar economic effect 
  to Qualifying Financial Instruments (xv, xvi) 
------------------------------------------------------------------------------------------------------ 
 Resulting situation after the triggering transaction 
------------------------------------------------------------------------------------------------------ 
 Type of        Exercise       Expiration     Exercise/       Number of voting      % of voting 
 financial       price         date           Conversion       rights instrument     rights (xix, 
 instrument                    (xvii)         period           refers to             xx) 
                                              (xviii) 
-------------  -------------  -------------  --------------  --------------------  ------------------- 
     CFD             -              -               -                               Nominal    Delta 
-------------  -------------  -------------  --------------                        --------  --------- 
                                                                   3,198,802         3.02%     3.02% 
        ---------------------------------------------------  --------------------  --------  --------- 
 
 Total (A+B+C) 
------------------------------------------------------------------------------------------------------ 
 Number of voting rights                        Percentage of voting rights 
---------------------------------------------  ------------------------------------------------------- 
                  3,198,802                                             3.02% 
---------------------------------------------  ------------------------------------------------------- 
 
 
 
 9. Chain of controlled undertakings through which the 
  voting rights and/or the 
  financial instruments are effectively held, if applicable: 
  (xxi) 
------------------------------------------------------------------------------------------ 
 
 
 Proxy Voting: 
------------------------------------------------------------------------------------------ 
 10. Name of the proxy holder: 
-------------------------------------------------------------  --------------------------- 
 11. Number of voting rights proxy 
  holder will cease 
  to hold: 
-------------------------------------------------------------  --------------------------- 
 12. Date on which proxy holder will 
  cease to hold 
  voting rights: 
-------------------------------------------------------------  --------------------------- 
 
 
  13. Additional information: 
-------------------------------------------------------------  --------------------------- 
 14. Contact name:                                               Antony Taylor, Skyepharma 
                                                                 PLC 
-------------------------------------------------------------  --------------------------- 
 15. Contact telephone number:                                  0207 881 1173 
-------------------------------------------------------------  ---------------------------

This information is provided by RNS

The company news service from the London Stock Exchange

END

HOLDVLBBQQFXBBB

(END) Dow Jones Newswires

June 08, 2016 03:32 ET (07:32 GMT)

Skyepharma (LSE:SKP)
Gráfica de Acción Histórica
De Nov 2024 a Dic 2024 Haga Click aquí para más Gráficas Skyepharma.
Skyepharma (LSE:SKP)
Gráfica de Acción Histórica
De Dic 2023 a Dic 2024 Haga Click aquí para más Gráficas Skyepharma.